Related Experiment Videos
Does or can human placenta produce prostacyclin?
Placenta
|January 1, 1986
Summary
The human placenta has the potential to produce prostacyclin (PGI2), but its actual in vivo production remains uncertain. This study quantified PGI2 synthase in early pregnancy placentae.
Area of Science:
- Reproductive biology
- Biochemistry
- Obstetrics
Background:
- Contradictory data exist regarding the human placenta's capacity for prostacyclin (PGI2) production.
- Prostacyclin plays crucial roles in vascular homeostasis and pregnancy maintenance.
Purpose of the Study:
- To resolve conflicting reports on placental prostacyclin production.
- To quantify prostacyclin (PGI2) synthase in first-trimester human placentae.
Main Methods:
- Quantification of PGI2 synthase using a specific immunoradiometric assay.
- Utilized two monoclonal antibodies for enzyme detection.
- Analyzed microsomal fractions from 12 first-trimester placentae.
Main Results:
- PGI2 synthase was detected in the microsomal fraction of all placentae studied.
- Enzyme concentrations were significantly lower than in bovine aortic microsomes and myometrium.
- Previous data discrepancies on placental PGI2 production appear to be minimal.
Conclusions:
- The human placenta possesses the biochemical potential to produce PGI2.
- The actual in vivo production of PGI2 by the placenta remains undetermined.
- Further research is needed to clarify the physiological role of placental PGI2 production.